NuVasive Buys Ellipse for $380M

Home/Financial/NuVasive Buys Ellipse for $380M

NuVasive Buys Ellipse for $380M

Excerpts of coverage:

  • “NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, and Ellipse Technologies, Inc. (“Ellipse”), a privately held medical technology company focused on revolutionizing procedural solutions for complex skeletal deformity, today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which NuVasive will acquire Ellipse for a $380 million upfront cash payment and a potential $30 million milestone payable in 2017 related to the achievement of specific revenue targets.” – NuVasive to Acquire Ellipse Technologies (press release)
  • “The price for Aliso Viejo-based Ellipse will be paid up-front, NuVasive chairman and chief executive Greg Lucier said in a conference call. It may include $30 million more payable in 2017 if revenue targets are met. Combining the two companies provides a “category-killing combination,” Lucier said. NuVasive’s line of minimally invasive products and procedures for spinal maladies meshes with Ellipse’s spinal bracing and limb-lengthening offerings for pediatric deformities.” – NuVasive pays $380M for Ellipse, San Diego Union-Tribune
  • “The acquisition expands NuVasive’s core expertise in spinal surgical products with highly differentiated technology that NuVasive plans to extend into new areas, such as degenerative spine disease. Lucier said the deal also represents “a very beneficial financial fit.” — NuVasive Buys Skeletal Specialist in First Deal under New CEO, Xconomy
January 6th, 2016|
X